Illumina Inc

Find Ratings Reports
ILMN : NASDAQ : Health Care
$155.39 up 5.30 | 3.50%
Today's Range: 145.28 - 154.00
Avg. Daily Volume: 1,154,900
07/27/16 - 10:46 AM ET

Financial Analysis


ILLUMINA INC's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. ILLUMINA INC is extremely liquid. Currently, the Quick Ratio is 3.63 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 22.65% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)571.76538.57
EBITDA ($mil)157.75197.04
EBIT ($mil)124.53166.94
Net Income ($mil)89.59136.66


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)1343.091366.49
Total Assets ($mil)3793.713499.09
Total Debt ($mil)1022.651301.2
Equity ($mil)1991.111623.33


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin75.2575.22
EBITDA Margin27.5836.58
Operating Margin21.7831.0
Sales Turnover0.590.57
Return on Assets10.9212.28
Return on Equity20.8126.49
Debt Q1 FY16 Q1 FY15
Current Ratio4.312.9
Debt/Capital0.340.44
Interest Expense8.5311.16
Interest Coverage14.6114.95


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)147.2144.1
Div / share0.00.0
EPS0.60.92
Book value / share13.5311.27
Institutional Own % n/a n/a
Avg Daily Volume1226202.01584159.0

Valuation


BUY. ILLUMINA INC's P/E ratio indicates a significant premium compared to an average of 34.13 for the Life Sciences Tools & Services industry and a significant premium compared to the S&P 500 average of 25.05. For additional comparison, its price-to-book ratio of 11.19 indicates a significant premium versus the S&P 500 average of 2.81 and a significant premium versus the industry average of 5.55. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, ILLUMINA INC proves to trade at a premium to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ILMN 54.43 Peers 34.13   ILMN 35.14 Peers 22.48

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

ILMN is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ILMN is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ILMN 38.11 Peers 25.21   ILMN 6.14 Peers 1.53

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

ILMN is trading at a significant premium to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ILMN trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ILMN 11.19 Peers 5.55   ILMN -3.81 Peers 34.26

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ILMN is trading at a significant premium to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ILMN is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ILMN 9.89 Peers 22.92   ILMN 13.83 Peers 6.67

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ILMN is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

ILMN has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades